{"id":"metaraminol","rwe":[{"pmid":"41889213","year":"2026","title":"Persistent Postoperative Hypotension Following Total Hip Replacement in a Patient with Schizophrenia.","finding":"","journal":"Annals of African medicine","studyType":"Clinical Study"},{"pmid":"41854017","year":"2026","title":"Efficacy and safety of different vasopressor infusions on feto-maternal outcomes in normotensive patients undergoing caesarean delivery: a systematic review and network meta-analysis of randomised controlled trials.","finding":"","journal":"Anaesthesia","studyType":"Clinical Study"},{"pmid":"41838001","year":"2026","title":"Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use: A Systematic Review and Meta-Analysis.","finding":"","journal":"JAMA network open","studyType":"Clinical Study"},{"pmid":"41731894","year":"2026","title":"Comments on \"Effects of prophylactic infusion of equivalent doses of metaraminol and norepinephrine for preventing spinal anesthesia-induced hypotension during cesarean delivery on fetal and maternal outcomes: a dual-center, non-inferiority randomized clinical trial\".","finding":"","journal":"International journal of surgery (London, England)","studyType":"Clinical Study"},{"pmid":"41688092","year":"2026","title":"An Integrated Engineering Approach to Intensify the Biocatalytic Metaraminol Synthesis.","finding":"","journal":"ChemSusChem","studyType":"Clinical Study"}],"tags":[{"label":"Indirectly Acting Sympathomimetic Amines","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Macrophage migration inhibitory factor","category":"target"},{"label":"MIF","category":"gene"},{"label":"ADRA1A","category":"gene"},{"label":"C01CA09","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Mature","category":"status"},{"label":"Low blood pressure","category":"indication"},{"label":"Approved 1950s","category":"decade"},{"label":"Adrenergic Agents","category":"pharmacology"},{"label":"Adrenergic Agonists","category":"pharmacology"},{"label":"Adrenergic alpha-1 Receptor Agonists","category":"pharmacology"},{"label":"Adrenergic alpha-Agonists","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sympathomimetics","category":"pharmacology"},{"label":"Vasoconstrictor Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":76.79,"date":"","count":10,"signal":"Confusion postoperative","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=77)"},{"llr":74.83,"date":"","count":10,"signal":"Mental status changes postoperative","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=75)"},{"llr":63.308,"date":"","count":23,"signal":"Anaphylactic reaction","source":"DrugCentral FAERS","actionTaken":"Reported 23 times (LLR=63)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=METARAMINOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:48:59.536398+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Metaraminol","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:49:08.710643+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:49:07.304660+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METARAMINOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:49:08.105600+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Adrenergic receptor alpha-1 agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:49:08.710313+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2062262/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:49:08.600861+00:00"}},"allNames":"aramine","offLabel":[],"synonyms":["metaraminol bitartrate","(-)-Metaraminol","(-)-erythro-Metaraminol","(-)-m-Hydroxynorephedrine","metaradrine","l-Metaraminol","m-Hydroxynorephedrine","metaraminol"],"timeline":[{"date":"1954-09-29","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"approvals":[{"date":"1954-09-29","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Aramine","ecosystem":[{"indication":"Low blood pressure","otherDrugs":[{"name":"dopamine","slug":"dopamine","company":""},{"name":"epinephrine","slug":"epinephrine","company":""},{"name":"mephentermine","slug":"mephentermine","company":"Baxter Hlthcare Corp"},{"name":"methoxamine","slug":"methoxamine","company":"Glaxosmithkline"}],"globalPrevalence":null}],"mechanism":{"target":"Macrophage migration inhibitory factor","novelty":"Follow-on","targets":[{"gene":"MIF","source":"DrugCentral","target":"Macrophage migration inhibitory factor","protein":"Macrophage migration inhibitory factor"},{"gene":"ADRA1A","source":"DrugCentral","target":"Alpha-1A adrenergic receptor","protein":"Alpha-1A adrenergic receptor"}],"modality":"Small Molecule","drugClass":"Indirectly Acting Sympathomimetic Amines","explanation":"","oneSentence":"","technicalDetail":"Aramine acts as an indirectly acting sympathomimetic amine by releasing norepinephrine from nerve terminals, which then stimulates alpha and beta-adrenergic receptors to increase vascular tone and cardiac output, ultimately leading to an increase in blood pressure."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Metaraminol","title":"Metaraminol","extract":"Metaraminol, also known as metaradrine and sold under the brand name Aramine among others, is a sympathomimetic medication which is used in the prevention and treatment of hypotension, particularly as a complication of anesthesia. It is given by intramuscular or intravenous administration.","wiki_history":"==History==\nMetaraminol was approved for medical use in the United States in September 1954.","wiki_society_and_culture":"==Society and culture==\n===Names===\nMetaraminol is the generic name of the medication and its  and , while its  is métaraminol and its  is metaraminolo. As the bitartrate salt, its generic name is metaraminol bitartrate and this is its  and , while metaraminol tartrate is its . A synonym of metaraminol is metaradrine. Brand names of metaraminol include Aramin, Aramine, and Pressonex, among others."},"commercial":{"launchDate":"1954","_launchSource":"DrugCentral (FDA 1954-09-29, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1721","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=METARAMINOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METARAMINOL","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Metaraminol","fields":["history","overview"],"source":"Wikipedia"},{"id":5,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T14:21:13.946538","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:49:10.538579+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"isoprenaline","drugSlug":"isoprenaline","fdaApproval":"1956-03-09","relationship":"same-class"},{"drugName":"norepinephrine","drugSlug":"norepinephrine","fdaApproval":"1950-07-13","patentExpiry":"Mar 8, 2041","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"dopamine","drugSlug":"dopamine","fdaApproval":"1974-02-25","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"phenylephrine","drugSlug":"phenylephrine","fdaApproval":"1952-01-21","patentExpiry":"Sep 26, 2036","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"dobutamine","drugSlug":"dobutamine","fdaApproval":"1978-07-18","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"methoxamine","drugSlug":"methoxamine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"mephentermine","drugSlug":"mephentermine","fdaApproval":"1951-12-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"midodrine","drugSlug":"midodrine","fdaApproval":"1996-09-06","genericCount":14,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fenoldopam","drugSlug":"fenoldopam","fdaApproval":"1997-09-23","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"arbutamine","drugSlug":"arbutamine","fdaApproval":"1997-09-12","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"epinephrine","drugSlug":"epinephrine","fdaApproval":"1948-11-19","patentExpiry":"Oct 20, 2036","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"ephedrine","drugSlug":"ephedrine","fdaApproval":"","patentExpiry":"May 16, 2040","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"droxidopa","drugSlug":"droxidopa","fdaApproval":"2014-02-18","genericCount":16,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"metaraminol","indications":{"approved":[{"name":"Low blood pressure","source":"DrugCentral","snomedId":45007003,"regulator":"FDA"}],"offLabel":[{"name":"Priapism","source":"DrugCentral","drugName":"METARAMINOL","evidenceCount":27,"evidenceLevel":"moderate"}],"pipeline":[]},"currentOwner":"Merck","drugCategory":"mature","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"isoprenaline","brandName":"isoprenaline","genericName":"isoprenaline","approvalYear":"1956","relationship":"same-class"},{"drugId":"norepinephrine","brandName":"norepinephrine","genericName":"norepinephrine","approvalYear":"1950","relationship":"same-class"},{"drugId":"dopamine","brandName":"dopamine","genericName":"dopamine","approvalYear":"1974","relationship":"same-class"},{"drugId":"phenylephrine","brandName":"phenylephrine","genericName":"phenylephrine","approvalYear":"1952","relationship":"same-class"},{"drugId":"dobutamine","brandName":"dobutamine","genericName":"dobutamine","approvalYear":"1978","relationship":"same-class"},{"drugId":"methoxamine","brandName":"methoxamine","genericName":"methoxamine","approvalYear":"","relationship":"same-class"},{"drugId":"mephentermine","brandName":"mephentermine","genericName":"mephentermine","approvalYear":"1951","relationship":"same-class"},{"drugId":"midodrine","brandName":"midodrine","genericName":"midodrine","approvalYear":"1996","relationship":"same-class"},{"drugId":"fenoldopam","brandName":"fenoldopam","genericName":"fenoldopam","approvalYear":"1997","relationship":"same-class"},{"drugId":"arbutamine","brandName":"arbutamine","genericName":"arbutamine","approvalYear":"1997","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07363109","phase":"NA","title":"Comparison of the Efficacy of Continuous Metaraminol Infusion Versus Continuous Norepinephrine Infusion for the Prevention of Hypotension During Cesarean Section Under Spinal Anaesthesia. A Randomised Controlled Trial.","status":"NOT_YET_RECRUITING","sponsor":"Aretaieion University Hospital","startDate":"2026-02","conditions":["Hypotension After Spinal Anesthesia","Hypotension During Cesarean Delivery"],"enrollment":80,"completionDate":"2029-03"},{"nctId":"NCT06551727","phase":"NA","title":"Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive Stroke","status":"ENROLLING_BY_INVITATION","sponsor":"Ruijin Hospital","startDate":"2024-08-15","conditions":["Stroke, Ischemic"],"enrollment":70,"completionDate":"2025-07-31"},{"nctId":"NCT05084599","phase":"PHASE4","title":"Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2022-05-12","conditions":["Cesarean Section Complications"],"enrollment":124,"completionDate":"2024-01-31"},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":["Acute Respiratory Distress Syndrome"],"enrollment":1000,"completionDate":"2023-12"},{"nctId":"NCT04991662","phase":"PHASE4","title":"Effect of Three Weight-adjusted Vasopressors for Elective Cesarean Delivery","status":"COMPLETED","sponsor":"Xuzhou Medical University","startDate":"2021-10-10","conditions":["Cesarean Section Complications"],"enrollment":78,"completionDate":"2021-12-03"},{"nctId":"NCT01451060","phase":"PHASE3","title":"Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean","status":"WITHDRAWN","sponsor":"Instituto Materno Infantil Prof. Fernando Figueira","startDate":"2011-06","conditions":["Preeclampsia","Pregnancy Toxemias"],"enrollment":0,"completionDate":"2014-07"},{"nctId":"NCT02245191","phase":"NA","title":"Ephedrine, Phenylephrine and Metaraminol Effects on Maternal Cardiac Output, Uterine Blood Flow and Fetal Circulation","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-07","conditions":["Preeclampsia"],"enrollment":60,"completionDate":""},{"nctId":"NCT01108874","phase":"PHASE2","title":"Up-Down Determination of the ED90 of Metaraminol to Treat Hypotension During Cesarean Section","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2009-11","conditions":["Hypotension"],"enrollment":48,"completionDate":"2010-08"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000178937","MMSL":"5061","NDDF":"001824","UNII":"818U2PZ2EH","VUID":"4017958","CHEBI":"CHEBI:6794","VANDF":"4017958","INN_ID":"34","RXNORM":"6805","UMLSCUI":"C0025575","chemblId":"CHEMBL2062262","ChEMBL_ID":"CHEMBL1201319","KEGG_DRUG":"D01019","DRUGBANK_ID":"DB00610","PUBCHEM_CID":"5906","SNOMEDCT_US":"372728001","IUPHAR_LIGAND_ID":"7229","SECONDARY_CAS_RN":"33402-03-8","MESH_DESCRIPTOR_UI":"D008680"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Merck","relationship":"Current Owner"}],"publicationCount":681,"therapeuticAreas":["Hematology"],"atcClassification":{"source":"DrugCentral","atcCode":"C01CA09","allCodes":["C01CA09"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 19","pmid":"41889213","title":"Persistent Postoperative Hypotension Following Total Hip Replacement in a Patient with Schizophrenia.","journal":"Annals of African medicine"},{"date":"2026 Mar 19","pmid":"41854017","title":"Efficacy and safety of different vasopressor infusions on feto-maternal outcomes in normotensive patients undergoing caesarean delivery: a systematic review and network meta-analysis of randomised controlled trials.","journal":"Anaesthesia"},{"date":"2026 Mar 2","pmid":"41838001","title":"Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use: A Systematic Review and Meta-Analysis.","journal":"JAMA network open"},{"date":"2026 Feb 1","pmid":"41731894","title":"Comments on \"Effects of prophylactic infusion of equivalent doses of metaraminol and norepinephrine for preventing spinal anesthesia-induced hypotension during cesarean delivery on fetal and maternal outcomes: a dual-center, non-inferiority randomized clinical trial\".","journal":"International journal of surgery (London, England)"},{"date":"2026 Feb 25","pmid":"41688092","title":"An Integrated Engineering Approach to Intensify the Biocatalytic Metaraminol Synthesis.","journal":"ChemSusChem"}],"companionDiagnostics":[],"genericManufacturers":5,"_genericFilersChecked":true,"genericManufacturerList":["Abraxis Pharm","Azurity","Elkins Sinn","Fresenius Kabi Usa","Gd Searle Llc"],"status":"approved","companyName":"Merck","companyId":"","modality":"Small molecule","firstApprovalDate":"1954","aiSummary":"Aramine is a small molecule medication. It is also known by the synonyms METARAMINOL.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1954-09-29T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1954-09-29T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1954-09-29T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1954-09-29T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1954-09-29T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1954-09-29T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:49:10.538579+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}